Lexicon Pharmaceuticals (LXRX) Free Cash Flow: 2009-2012
Historic Free Cash Flow for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to -$20.5 million.
- Lexicon Pharmaceuticals' Free Cash Flow rose 9.49% to -$20.5 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$95.0 million, marking a year-over-year decrease of 6.52%. This contributed to the annual value of -$179.8 million for FY2024, which is 10.74% down from last year.
- Lexicon Pharmaceuticals' Free Cash Flow amounted to -$20.5 million in Q4 2012, which was up 18.21% from -$25.1 million recorded in Q3 2012.
- Over the past 5 years, Lexicon Pharmaceuticals' Free Cash Flow peaked at -$17.3 million during Q4 2009, and registered a low of -$28.2 million during Q1 2009.
- For the 3-year period, Lexicon Pharmaceuticals' Free Cash Flow averaged around -$22.3 million, with its median value being -$22.0 million (2011).
- Its Free Cash Flow has fluctuated over the past 5 years, first increased by 22.92% in 2010, then decreased by 23.54% in 2012.
- Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Free Cash Flow stood at -$17.3 million in 2009, then decreased by 14.00% to -$19.7 million in 2010, then declined by 15.42% to -$22.7 million in 2011, then climbed by 9.49% to -$20.5 million in 2012.
- Its last three reported values are -$20.5 million in Q4 2012, -$25.1 million for Q3 2012, and -$22.1 million during Q2 2012.